LDK378
Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.
Product Specifications
CAS Number
1032900-25-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
558.14
Molecular Formula
C28H36ClN5O3S
Notes
Research use only, not for human use.
Receptor
ALK| FLT3| IGF-1R| Insulin Receptor| STK22D
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-8726R-APC-Cy5.5 100 µL
BZW2 Polyclonal Antibody, APC-Cy5.5 Conjugated
Sign In for Pricing
View Details 
